| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Review |
Department of Molecular Genetics, University of Illinois at Chicago, Chicago, Illinois 60607-7170
Cell senescence is broadly defined as the physiological program of terminal growth arrest, which can be triggered by alterations of telomeres or by different forms of stress. Neoplastic transformation involves events that inhibit the program of senescence, and tumor cells were believed until recently to have lost the ability to senesce. It has now become apparent, however, that tumor cells can be readily induced to undergo senescence by genetic manipulations or by treatment with chemotherapeutic drugs, radiation, or differentiating agents. Treatment-induced senescence, which has both similarities with, and differences from, replicative senescence of normal cells, was shown to be one of the key determinants of tumor response to therapy in vitro and in vivo. Although senescent cells do not proliferate, they remain metabolically active and produce secreted proteins with both tumor-suppressing and tumor-promoting activities. Expression of tumor-promoting factors by senescent cells is mediated, at least in part, by senescence-associated cyclin-dependent kinase inhibitors such as p21Waf1/Cip1/Sdi1. Clinical and preclinical studies indicate that expression of different biological classes of senescence-associated growth-regulatory genes in tumor cells has significant prognostic implications. Elucidation of the genes and regulatory mechanisms that determine different aspects of tumor senescence makes it possible to design new therapeutic approaches to improving the efficacy and to decreasing the side effects of cancer therapy.
This article has been cited by other articles:
|
|
 |
|
  J. T. Zilfou and S. W. Lowe Tumor Suppressive Functions of p53 Cold Spring Harb Perspect Biol, November 1, 2009; 1(5): a001883 - a001883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Huang, D. Deo, M. Xia, and L. T. Vassilev Pharmacologic p53 Activation Blocks Cell Cycle Progression but Fails to Induce Senescence in Epithelial Cancer Cells Mol. Cancer Res., September 1, 2009; 7(9): 1497 - 1509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Walia, M. Ding, S. Kumar, D. Nie, L. S. Premkumar, and R. C. Elble hCLCA2 Is a p53-Inducible Inhibitor of Breast Cancer Cell Proliferation Cancer Res., August 15, 2009; 69(16): 6624 - 6632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Soriani, A. Zingoni, C. Cerboni, M. L. Iannitto, M. R. Ricciardi, V. Di Gialleonardo, M. Cippitelli, C. Fionda, M. T. Petrucci, A. Guarini, et al. ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype Blood, April 9, 2009; 113(15): 3503 - 3511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Tierno, C. A. Kitchens, B. Petrik, T. H. Graham, P. Wipf, F. L. Xu, W. S. Saunders, B. S. Raccor, R. Balachandran, B. W. Day, et al. Microtubule Binding and Disruption and Induction of Premature Senescence by Disorazole C1 J. Pharmacol. Exp. Ther., March 1, 2009; 328(3): 715 - 722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Krizhanovsky, W. Xue, L. Zender, M. Yon, E. Hernando, and S.W. Lowe Implications of Cellular Senescence in Tissue Damage Response, Tumor Suppression, and Stem Cell Biology Cold Spring Harb Symp Quant Biol, January 15, 2009; (2009) sqb.2008.73.048v1. [Abstract] [PDF]
|
|
|
|
|
|
B. D. Lehmann, M. S. Paine, A. M. Brooks, J. A. McCubrey, R. H. Renegar, R. Wang, and D. M. Terrian Senescence-Associated Exosome Release from Human Prostate Cancer Cells Cancer Res., October 1, 2008; 68(19): 7864 - 7871. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Li, L. Tang, P. C. Roberts, J. M. Kraniak, A. L. Fridman, O. I. Kulaeva, O. S. Tehrani, and M. A. Tainsky Interferon Regulatory Factors IRF5 and IRF7 Inhibit Growth and Induce Senescence in Immortal Li-Fraumeni Fibroblasts Mol. Cancer Res., May 1, 2008; 6(5): 770 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Oliva, M. C. Caino, A. M. Senderowicz, and M. G. Kazanietz S-Phase-specific Activation of PKC{alpha} Induces Senescence in Non-small Cell Lung Cancer Cells J. Biol. Chem., February 29, 2008; 283(9): 5466 - 5476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Abrahams, S. Mowla, M. I. Parker, C. R. Goding, and S. Prince UV-mediated Regulation of the Anti-senescence Factor Tbx2 J. Biol. Chem., January 25, 2008; 283(4): 2223 - 2230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Funasaka, H. Hu, V. Hogan, and A. Raz Down-regulation of Phosphoglucose Isomerase/Autocrine Motility Factor Expression Sensitizes Human Fibrosarcoma Cells to Oxidative Stress Leading to Cellular Senescence J. Biol. Chem., December 14, 2007; 282(50): 36362 - 36369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Xue, M. Haber, C. Flemming, G. M. Marshall, R. B. Lock, K. L. MacKenzie, K. V. Gurova, M. D. Norris, and A. V. Gudkov p53 Determines Multidrug Sensitivity of Childhood Neuroblastoma Cancer Res., November 1, 2007; 67(21): 10351 - 10360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Efeyan, A. Ortega-Molina, S. Velasco-Miguel, D. Herranz, L. T. Vassilev, and M. Serrano Induction of p53-Dependent Senescence by the MDM2 Antagonist Nutlin-3a in Mouse Cells of Fibroblast Origin Cancer Res., August 1, 2007; 67(15): 7350 - 7357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Hornsby Senescence As an Anticancer Mechanism J. Clin. Oncol., May 10, 2007; 25(14): 1852 - 1857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Akalu, J. M. Roth, M. Caunt, D. Policarpio, L. Liebes, and P. C. Brooks Inhibition of Angiogenesis and Tumor Metastasis by Targeting a Matrix Immobilized Cryptic Extracellular Matrix Epitope in Laminin Cancer Res., May 1, 2007; 67(9): 4353 - 4363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Yaglom, V. L. Gabai, and M. Y. Sherman High Levels of Heat Shock Protein Hsp72 in Cancer Cells Suppress Default Senescence Pathways Cancer Res., March 1, 2007; 67(5): 2373 - 2381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Bihani, A. Chicas, C. P.-K. Lo, and A. W. Lin Dissecting the Senescence-like Program in Tumor Cells Activated by Ras Signaling J. Biol. Chem., January 26, 2007; 282(4): 2666 - 2675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ueda, K. Fukamachi, Y. Matsuoka, N. Takasuka, F. Takeshita, A. Naito, M. Iigo, D. B. Alexander, M. A. Moore, I. Saito, et al. Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas Carcinogenesis, December 1, 2006; 27(12): 2497 - 2510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Chen, M. Dokmanovic, W. D. Stein, R. J. Ardecky, and I. B. Roninson Agonist and Antagonist of Retinoic Acid Receptors Cause Similar Changes in Gene Expression and Induce Senescence-like Growth Arrest in MCF-7 Breast Carcinoma Cells. Cancer Res., September 1, 2006; 66(17): 8749 - 8761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ozturk, E. Erdal, M. Mumcuoglu, K. C. Akcali, O. Yalcin, S. Senturk, A. Arslan-Ergul, B. Gur, I. Yulug, R. Cetin-Atalay, et al. Reprogramming of replicative senescence in hepatocellular carcinoma-derived cells PNAS, February 14, 2006; 103(7): 2178 - 2183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Ranganathan, L. Zhang, A. P. Adam, and J. A. Aguirre-Ghiso Functional Coupling of p38-Induced Up-regulation of BiP and Activation of RNA-Dependent Protein Kinase-Like Endoplasmic Reticulum Kinase to Drug Resistance of Dormant Carcinoma Cells Cancer Res., February 1, 2006; 66(3): 1702 - 1711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-M. Aliouat-Denis, N. Dendouga, I. Van den Wyngaert, H. Goehlmann, U. Steller, I. van de Weyer, N. Van Slycken, L. Andries, S. Kass, W. Luyten, et al. p53-Independent Regulation of p21Waf1/Cip1 Expression and Senescence by Chk2 Mol. Cancer Res., November 1, 2005; 3(11): 627 - 634. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Douarre, D. Gomez, H. Morjani, J.-M. Zahm, M.-F. O'Donohue, L. Eddabra, P. Mailliet, J.-F. Riou, and C. Trentesaux Overexpression of Bcl-2 is associated with apoptotic resistance to the G-quadruplex ligand 12459 but is not sufficient to confer resistance to long-term senescence Nucleic Acids Res., April 14, 2005; 33(7): 2192 - 2203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Roberson, S. J. Kussick, E. Vallieres, S.-Y. J. Chen, and D. Y. Wu Escape from Therapy-Induced Accelerated Cellular Senescence in p53-Null Lung Cancer Cells and in Human Lung Cancers Cancer Res., April 1, 2005; 65(7): 2795 - 2803. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Roth, A. Akalu, A. Zelmanovich, D. Policarpio, B. Ng, S. MacDonald, S. Formenti, L. Liebes, and P. C. Brooks Recombinant {alpha}2(IV)NC1 Domain Inhibits Tumor Cell-Extracellular Matrix Interactions, Induces Cellular Senescence, and Inhibits Tumor Growth in Vivo Am. J. Pathol., March 1, 2005; 166(3): 901 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Trost, E. U. Lausch, S. A. Fees, S. Schmitt, T. Enklaar, D. Reutzel, L. R. Brixel, P. Schmidtke, M. Maringer, I. B. Schiffer, et al. Premature Senescence Is a Primary Fail-safe Mechanism of ERBB2-Driven Tumorigenesis in Breast Carcinoma Cells Cancer Res., February 1, 2005; 65(3): 840 - 849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ussar and T. Voss MEK1 and MEK2, Different Regulators of the G1/S Transition J. Biol. Chem., October 15, 2004; 279(42): 43861 - 43869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Maley, B. J. Reid, and S. Forrest Cancer Prevention Strategies That Address the Evolutionary Dynamics of Neoplastic Cells: Simulating Benign Cell Boosters and Selection for Chemosensitivity Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1375 - 1384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Nickoloff, M. W. Lingen, B.-D. Chang, M. Shen, M. Swift, J. Curry, P. Bacon, B. Bodner, and I. B. Roninson Tumor Suppressor Maspin Is Up-Regulated during Keratinocyte Senescence, Exerting a Paracrine Antiangiogenic Activity Cancer Res., May 1, 2004; 64(9): 2956 - 2961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Akiyama, T. Hideshima, M. A. Shammas, T. Hayashi, M. Hamasaki, Y.-T. Tai, P. Richardson, S. Gryaznov, N. C. Munshi, and K. C. Anderson Effects of Oligonucleotide N3'->P5' Thio-phosphoramidate (GRN163) Targeting Telomerase RNA in Human Multiple Myeloma Cells Cancer Res., October 1, 2003; 63(19): 6187 - 6194. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
